Kearns-Sayer syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 21: Line 21:
'''Kearns-Sayer syndrome''' is a mitochondrial disorder featuring the triad of: <ref>Adams et al., Principles of Neurology, 6th ed, p984</ref>
'''Kearns-Sayer syndrome''' is a mitochondrial disorder featuring the triad of: <ref>Adams et al., Principles of Neurology, 6th ed, p984</ref>


* chronic progressive external ophthalmoplegia
* chronic progressive external [[ophthalmoplegia]]
* Cardiomyopathies with conduction block
* [[Cardiomyopathies]] with conduction block
* Retinitis pigmentosa
* [[Retinitis pigmentosa]]


Disease onset is in the first or second decade.  
Disease onset is in the first or second decade.  
Line 29: Line 29:
* Elevated CSF protein
* Elevated CSF protein
* sensorineural deafness  
* sensorineural deafness  
* seizures
* [[seizure]]s
* pyramidal signs may also be present
* pyramidal signs
* Ragged-red fibers are found on muscle biopsy.
* Ragged-red fibers are found on muscle biopsy.

Revision as of 07:54, 9 January 2009

Kearns-Sayer syndrome

WikiDoc Resources for Kearns-Sayer syndrome

Articles

Most recent articles on Kearns-Sayer syndrome

Most cited articles on Kearns-Sayer syndrome

Review articles on Kearns-Sayer syndrome

Articles on Kearns-Sayer syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Kearns-Sayer syndrome

Images of Kearns-Sayer syndrome

Photos of Kearns-Sayer syndrome

Podcasts & MP3s on Kearns-Sayer syndrome

Videos on Kearns-Sayer syndrome

Evidence Based Medicine

Cochrane Collaboration on Kearns-Sayer syndrome

Bandolier on Kearns-Sayer syndrome

TRIP on Kearns-Sayer syndrome

Clinical Trials

Ongoing Trials on Kearns-Sayer syndrome at Clinical Trials.gov

Trial results on Kearns-Sayer syndrome

Clinical Trials on Kearns-Sayer syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Kearns-Sayer syndrome

NICE Guidance on Kearns-Sayer syndrome

NHS PRODIGY Guidance

FDA on Kearns-Sayer syndrome

CDC on Kearns-Sayer syndrome

Books

Books on Kearns-Sayer syndrome

News

Kearns-Sayer syndrome in the news

Be alerted to news on Kearns-Sayer syndrome

News trends on Kearns-Sayer syndrome

Commentary

Blogs on Kearns-Sayer syndrome

Definitions

Definitions of Kearns-Sayer syndrome

Patient Resources / Community

Patient resources on Kearns-Sayer syndrome

Discussion groups on Kearns-Sayer syndrome

Patient Handouts on Kearns-Sayer syndrome

Directions to Hospitals Treating Kearns-Sayer syndrome

Risk calculators and risk factors for Kearns-Sayer syndrome

Healthcare Provider Resources

Symptoms of Kearns-Sayer syndrome

Causes & Risk Factors for Kearns-Sayer syndrome

Diagnostic studies for Kearns-Sayer syndrome

Treatment of Kearns-Sayer syndrome

Continuing Medical Education (CME)

CME Programs on Kearns-Sayer syndrome

International

Kearns-Sayer syndrome en Espanol

Kearns-Sayer syndrome en Francais

Business

Kearns-Sayer syndrome in the Marketplace

Patents on Kearns-Sayer syndrome

Experimental / Informatics

List of terms related to Kearns-Sayer syndrome

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms: Kearns Syndrome, Kearn-Sayre Mitochondrial Cytopathy, Kearns' Syndrome, Kearns-Sayre-Shy-Daroff Syndrome

Kearns-Sayer syndrome is a mitochondrial disorder featuring the triad of: [1]

Disease onset is in the first or second decade.

  • Elevated CSF protein
  • sensorineural deafness
  • seizures
  • pyramidal signs
  • Ragged-red fibers are found on muscle biopsy.
  1. Adams et al., Principles of Neurology, 6th ed, p984